A 4 year trial of Tiotropium in Chronic Obstructive Pulmonary disease: A critique of this article. UPLIFT trial
The authors did a good job in the back ground section describing the previous studies. It would been nicer it they can mention any studies comparing Ipatropium and Titropium
Methods
Good study design. sample size calculated.Multi center. did not mention the race percentage in the demographic section. Does it matter to the authors? Coe n guys, wake up
Demographic table 45% on anticholinergics. But in page 2 people on other anitchlinergic were excluded?
smokers changed their pattern during the study. So the result are screwed??
Over all head to head Tiotropium and Placebo - P value not significant
Where are the benefits.
significant decrease in exacerbations, hospital admissions.
Interesting findings
Decreased Mi in Tiotropium group
final advice to COPD patients
Take the drug
Comments